RGEN
Companies
NASDAQ
Repligen Corporation
Health Care
$117.54
-$26.40 (-18.34%)
Price Chart
Overview
About RGEN
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Market Cap
$8.1B
Volume
99.0M
Avg. Volume
102.9M
P/E Ratio
71.67977
Dividend Yield
0.00%
Employees
1.4K
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Medical Instruments & Supplies
Website
Risk & Correlation Analysis
Market Correlation
0.62
Low Correlation
Volatility
High (0.51)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RGEN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$8.1B
Volume99.0M
P/E Ratio71.68
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 29, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025